<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00286754</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 04-170</org_study_id>
    <nct_id>NCT00286754</nct_id>
  </id_info>
  <brief_title>A Behavioral Intervention To Improve Hypertension Control In Veterans</brief_title>
  <official_title>A Behavioral Intervention to Improve Hypertension Control in Veterans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a stage-matched intervention (SMI) will
      lower BP and improve treatment adherence compared to usual care (UC) or a health education
      intervention (HEI) in veterans with uncontrolled BP. The study will also examine the effect
      of SMI on patient's health-related quality of life, satisfaction, acceptability and determine
      its cost-effectiveness.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a randomized controlled trial to evaluate the effect of telephone-delivered
      interventions (SMI and HEI) to improve BP control.

      Veterans with uncontrolled hypertension (n=533) will be randomized equally to 3 groups: 1)
      The SMI will use the Transtheoretical model (TTM) as the unifying framework. Veterans will
      receive TTM stage-matched counseling for exercise, diet, and medications via monthly
      counseling sessions. A social worker (SW) will assess each participant's behavior and deliver
      the appropriate tailored SMI based on their stage of change, decisional balance,
      self-efficacy and the skills model questions. 2) The HEI group receives monthly telephone
      calls by a SW during which they will receive education about hypertension management. 3) The
      UC group participates in all the in-person visits but does not receive monthly calls.

      There will be an initial 6-month active intervention phase followed by a 6 month monitoring
      phase to assess sustainability. All participants will visit the VAMC's at baseline and at 3,
      6, and 12 months. Outcomes of interest include BP; adherence (to diet, exercise and
      medications); quality of life; satisfaction; acceptability; cost and cost-effectiveness.
      Patients will be blinded to which of the intervention arms (SMI or HEI) they are in, SW's
      will be blinded to patient's BP and staff measuring outcomes will be blinded to study
      assignment. The study will be analyzed using longitudinal data analysis methods using an
      intention to treat strategy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2006</start_date>
  <completion_date type="Actual">September 2011</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood Pressure Control</measure>
    <time_frame>6 months</time_frame>
    <description>Blood pressure Control at 6 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>6 months</time_frame>
    <description>Mean systolic Blood Pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Proportion With BP Under Control From Baseline to 6 Months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Systolic Blood Pressure From Baseline to 6 Months</measure>
    <time_frame>Baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Number of Cardio Exercise Hours From Baseline to 6 Months</measure>
    <time_frame>baseline and 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Morisky Score From Baseline to 6 Months</measure>
    <time_frame>baseline and 6 months</time_frame>
    <description>Morkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4. A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diet Stage of Change</measure>
    <time_frame>6 months</time_frame>
    <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise Stage of Change</measure>
    <time_frame>6 months</time_frame>
    <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Stage of Change</measure>
    <time_frame>6 months</time_frame>
    <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">533</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Stage-matched intervention (SMI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stage-matched intervention (SMI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Health Education Intervention (HEI)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Health Education Intervention (HEI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care (UC)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care (UC)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMI</intervention_name>
    <description>Stage-matched intervention</description>
    <arm_group_label>Stage-matched intervention (SMI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HEI</intervention_name>
    <description>Health Education Intervention</description>
    <arm_group_label>Stage-matched intervention (SMI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>UC</intervention_name>
    <description>Usual Care</description>
    <arm_group_label>Stage-matched intervention (SMI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>SMI</intervention_name>
    <description>Stage-matched intervention</description>
    <arm_group_label>Health Education Intervention (HEI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HEI</intervention_name>
    <description>Health Education Intervention</description>
    <arm_group_label>Health Education Intervention (HEI)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>UC</intervention_name>
    <description>Usual Care</description>
    <arm_group_label>Health Education Intervention (HEI)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients receiving continuity of care in the outpatient clinics will be eligible. This
             will be operationalized as 2 visits in the previous year.

          -  Adults (= 21 years) with hypertension, on antihypertensive medication for = 1 year,
             and who have current uncontrolled BP will be enrolled.

        Patients with CVD:

          -  chronic stable angina

          -  unstable angina

          -  uncomplicated myocardial infarction

          -  coronary artery bypass surgery

          -  percutaneous coronary angioplasty

          -  atherectomy or stent placement

          -  chronic stable angina pectoris

          -  stable Class I or Class II congestive heart failure

          -  stroke

          -  peripheral vascular disease

        will be entered into the study if the CVD event or diagnosis occurred = 6 months ago.

        Exclusion Criteria:

        Patients with limited life expectancy (&lt; 1 year) due to severe co-existing non-CVD disease
        such as:

          -  terminal illnesses such as terminal cancer

          -  CVD &lt; 6 months ago

          -  Class III or IV CHF

          -  severe psychiatric illness such as psychosis

          -  manic depression

          -  alcohol abuse (&gt; 21 drinks/week)

          -  serious chronic conditions like AIDS

          -  tuberculosis

          -  lupus

          -  and end-stage renal failure

        will be excluded.

          -  Other exclusions include inability to understand English

          -  Lack of a landline telephone

          -  Unable to follow the study protocol

          -  Recent major surgery (&lt; 3 months)

          -  Patients who are temporarily in the area and plan to move in &lt; 1 year or will not be
             available for follow-up

          -  Those unable to provide informed consent.

          -  All patients excluded and reason for exclusion will be recorded.

          -  Prior to recruitment, each patient will be informed about the study and informed
             consent obtained.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sundar Natarajan, MD MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA New York Harbor Health Care System</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA New York Harbor Health Care System</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Ulmer M, Robinaugh D, Friedberg JP, Lipsitz SR, Natarajan S. Usefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral intervention. Contemp Clin Trials. 2008 Sep;29(5):705-10. doi: 10.1016/j.cct.2008.04.005. Epub 2008 May 6.</citation>
    <PMID>18565801</PMID>
  </results_reference>
  <results_reference>
    <citation>Friedberg JP, Lipsitz SR, Natarajan S. Challenges and recommendations for blinding in behavioral interventions illustrated using a case study of a behavioral intervention to lower blood pressure. Patient Educ Couns. 2010 Jan;78(1):5-11. doi: 10.1016/j.pec.2009.04.009. Epub 2009 Jun 13. Review.</citation>
    <PMID>19525084</PMID>
  </results_reference>
  <results_reference>
    <citation>Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, Lipsitz SR, Natarajan S. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015 Feb;65(2):440-6. doi: 10.1161/HYPERTENSIONAHA.114.03483. Epub 2014 Nov 17.</citation>
    <PMID>25403606</PMID>
  </results_reference>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 1, 2006</study_first_submitted>
  <study_first_submitted_qc>February 1, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2006</study_first_posted>
  <results_first_submitted>January 21, 2015</results_first_submitted>
  <results_first_submitted_qc>April 8, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 9, 2015</results_first_posted>
  <last_update_submitted>May 8, 2015</last_update_submitted>
  <last_update_submitted_qc>May 8, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hypertension</keyword>
  <keyword>Behavior modification</keyword>
  <keyword>Randomized controlled trial</keyword>
  <keyword>Treatment effectiveness</keyword>
  <keyword>Telemedicine</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Stage-matched Intervention (SM)</title>
          <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
        </group>
        <group group_id="P2">
          <title>Health Education Intervention (HEI)</title>
          <description>6 monthly phone calls of non-tailored counseling for diet, medication and exercise</description>
        </group>
        <group group_id="P3">
          <title>Usual Care (UC)</title>
          <description>treatment as usual with no additional counseling</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="176"/>
                <participants group_id="P2" count="177"/>
                <participants group_id="P3" count="180"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="159"/>
                <participants group_id="P3" count="170"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
                <participants group_id="P2" count="18"/>
                <participants group_id="P3" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="2"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Moved out of state</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Stage-Matched Intervention (SMI)</title>
          <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
        </group>
        <group group_id="B2">
          <title>Health Education Intervention (HEI)</title>
          <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
        </group>
        <group group_id="B3">
          <title>Usual Care (UC)</title>
          <description>treatment as usual for hypertension</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="176"/>
            <count group_id="B2" value="177"/>
            <count group_id="B3" value="180"/>
            <count group_id="B4" value="533"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age and Standard Deviation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66.4" spread="8.8"/>
                    <measurement group_id="B2" value="66.5" spread="12.8"/>
                    <measurement group_id="B3" value="65.4" spread="10.2"/>
                    <measurement group_id="B4" value="66.1" spread="18.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="174"/>
                    <measurement group_id="B2" value="176"/>
                    <measurement group_id="B3" value="176"/>
                    <measurement group_id="B4" value="526"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>White (non-Hispanic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="71"/>
                    <measurement group_id="B4" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black (non-Hispanic)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65"/>
                    <measurement group_id="B2" value="77"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="212"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="82"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="10"/>
                    <measurement group_id="B4" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Marital status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not Married</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="117"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="110"/>
                    <measurement group_id="B4" value="337"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>High school graduate or below</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="72"/>
                    <measurement group_id="B2" value="89"/>
                    <measurement group_id="B3" value="87"/>
                    <measurement group_id="B4" value="248"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Some college or higher</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104"/>
                    <measurement group_id="B2" value="88"/>
                    <measurement group_id="B3" value="93"/>
                    <measurement group_id="B4" value="285"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Employment status</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Employed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="41"/>
                    <measurement group_id="B4" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not employed</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="147"/>
                    <measurement group_id="B2" value="136"/>
                    <measurement group_id="B3" value="139"/>
                    <measurement group_id="B4" value="422"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Campus</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Manhattan campus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="96"/>
                    <measurement group_id="B2" value="96"/>
                    <measurement group_id="B3" value="97"/>
                    <measurement group_id="B4" value="289"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Brooklyn campus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="83"/>
                    <measurement group_id="B4" value="244"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoking</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Current smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="32"/>
                    <measurement group_id="B4" value="99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Current non-smoker</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="141"/>
                    <measurement group_id="B2" value="145"/>
                    <measurement group_id="B3" value="148"/>
                    <measurement group_id="B4" value="434"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.5" spread="5.2"/>
                    <measurement group_id="B2" value="31.2" spread="5.8"/>
                    <measurement group_id="B3" value="30.0" spread="4.8"/>
                    <measurement group_id="B4" value="30.5" spread="5.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Blood pressure control</title>
          <description>Controlled BP was defined as systolic BP (SBP) less than130 mm Hg or Diastolic BP (DBP) less than 80 mm Hg in diabetes mellitus or chronic kidney disease, or SBP less than140 mm Hg or DBP less than 90 mm Hg in all others as per the BP guidelines at the time of the study.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>BP controlled</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="72"/>
                    <measurement group_id="B3" value="80"/>
                    <measurement group_id="B4" value="227"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BP not controlled</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="101"/>
                    <measurement group_id="B2" value="105"/>
                    <measurement group_id="B3" value="100"/>
                    <measurement group_id="B4" value="306"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diabetes Mellitus</title>
          <description>From chart review</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71"/>
                    <measurement group_id="B2" value="83"/>
                    <measurement group_id="B3" value="81"/>
                    <measurement group_id="B4" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No diabetes mellitus</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                    <measurement group_id="B2" value="94"/>
                    <measurement group_id="B3" value="99"/>
                    <measurement group_id="B4" value="298"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ischemic Heart Disease (IHD)</title>
          <description>self-reported</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>History of IHD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="22"/>
                    <measurement group_id="B3" value="23"/>
                    <measurement group_id="B4" value="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No history of IHD</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="153"/>
                    <measurement group_id="B2" value="155"/>
                    <measurement group_id="B3" value="157"/>
                    <measurement group_id="B4" value="465"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of revascularization</title>
          <description>self-reported</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>History of revascularization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="28"/>
                    <measurement group_id="B3" value="31"/>
                    <measurement group_id="B4" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No history of revascularization</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="149"/>
                    <measurement group_id="B2" value="149"/>
                    <measurement group_id="B3" value="149"/>
                    <measurement group_id="B4" value="447"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hyperlipidemia</title>
          <description>Hyperlipidemia was defined as LDL cholesterol of greater than or equal to 100 mg/dL from laboratory results</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="52"/>
                    <measurement group_id="B4" value="129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>No hyperlipidemia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="137"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="128"/>
                    <measurement group_id="B4" value="404"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Estimated glomerular filtration rate (EGFR)</title>
          <units>mL/min/1.73m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.9" spread="25.5"/>
                    <measurement group_id="B2" value="83.2" spread="46.3"/>
                    <measurement group_id="B3" value="80.6" spread="28.4"/>
                    <measurement group_id="B4" value="81.3" spread="35.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic Blood Pressure, mm Mg</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="136.0" spread="11.8"/>
                    <measurement group_id="B2" value="137.2" spread="17.7"/>
                    <measurement group_id="B3" value="137.0" spread="12.9"/>
                    <measurement group_id="B4" value="136.7" spread="15.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic blood pressure</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75.5" spread="9.3"/>
                    <measurement group_id="B2" value="76.1" spread="11.6"/>
                    <measurement group_id="B3" value="75.0" spread="11.1"/>
                    <measurement group_id="B4" value="75.5" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Aerobic exercise</title>
          <units>hours per week</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.3" spread="8.1"/>
                    <measurement group_id="B2" value="4.5" spread="5.9"/>
                    <measurement group_id="B3" value="5.0" spread="6.7"/>
                    <measurement group_id="B4" value="4.9" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medication adherence by Morisky scale</title>
          <description>Morisky medication-taking scale is a 4-item questionnaire scored from 0-4, with 4 being most adherent and less than 4 being considered nonadherent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.4" spread="0.93"/>
                    <measurement group_id="B2" value="3.2" spread="0.67"/>
                    <measurement group_id="B3" value="3.3" spread="0.94"/>
                    <measurement group_id="B4" value="3.3" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of antihypertensive medications</title>
          <units>medications</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.7" spread="1.5"/>
                    <measurement group_id="B2" value="2.8" spread="1.3"/>
                    <measurement group_id="B3" value="2.7" spread="1.3"/>
                    <measurement group_id="B4" value="2.7" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diet stage of change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="69"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="70"/>
                    <measurement group_id="B4" value="206"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="110"/>
                    <measurement group_id="B4" value="327"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Exercise Stage of Change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence19, 20 due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="110"/>
                    <measurement group_id="B3" value="108"/>
                    <measurement group_id="B4" value="343"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation, or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51"/>
                    <measurement group_id="B2" value="67"/>
                    <measurement group_id="B3" value="72"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Medication Stage of Change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="170"/>
                    <measurement group_id="B3" value="166"/>
                    <measurement group_id="B4" value="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="14"/>
                    <measurement group_id="B4" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Blood Pressure Control</title>
        <description>Blood pressure Control at 6 months</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Blood Pressure Control</title>
          <description>Blood pressure Control at 6 months</description>
          <units>proportion of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>BP controlled</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.646"/>
                    <measurement group_id="O2" value="0.543"/>
                    <measurement group_id="O3" value="0.458"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>BP not controlled</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.354"/>
                    <measurement group_id="O2" value="0.457"/>
                    <measurement group_id="O3" value="0.542"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The study was an effectiveness trial of 2 active interventions, each compared with an active standard of care control group. We expected that 54% of patients on BP-lowering therapy would be properly controlled with HEI and 43% with UC, whereas we expected SMI to increase this to 69% control in 6 months. BP control and SBP were compared at 6 months across treatment arms using a 2.5% type I error (Bonferroni adjustment), ie, 1.25% for each of the 4 comparisons.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>BP control and SBP were compared at 6 months across treatment arms using a Bonferroni adjustment of 1.25% for each of the 4 comparisons (SMI versus UC and HEI versus UC for BP control and SBP separately). This p-value is for comparison of SMI vs. UC</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.108</p_value>
            <p_value_desc>BP control and SBP were compared at 6 months across treatment arms using a Bonferroni adjustment of 1.25% for each of the 4 comparisons (SMI versus UC and HEI versus UC for BP control and SBP separately). This p-value is for comparison of HEI vs. UC</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Systolic Blood Pressure</title>
        <description>Mean systolic Blood Pressure</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>Mean systolic Blood Pressure</description>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131.2" lower_limit="129.1" upper_limit="133.3"/>
                    <measurement group_id="O2" value="131.8" lower_limit="129.9" upper_limit="133.7"/>
                    <measurement group_id="O3" value="134.7" lower_limit="132.7" upper_limit="136.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>The study was designed as an effectiveness trial of 2 active interventions, each compared with an active standard of care control group. The study was not powered to test comparisons between the 2 active intervention arms.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.009</p_value>
            <p_value_desc>BP control and SBP were compared at 6 months across treatment arms using a 2.5% type I error (Bonferroni adjustment), 1.25% for each of the 4 comparisons (SMI versus UC and HEI vs UC for BP control and SBP separately). This p-value is for SMI vs UC</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.047</p_value>
            <p_value_desc>BP control and SBP were compared at 6 months across treatment arms using a Bonferroni adjustment of 1.25% for each of the 4 comparisons (SMI versus UC and HEI vs UC for BP control and SBP separately). This p-value is for comparison of HEI vs. UC</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Proportion With BP Under Control From Baseline to 6 Months</title>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly phone calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Proportion With BP Under Control From Baseline to 6 Months</title>
          <units>Proportion of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value=".197"/>
                    <measurement group_id="O2" value=".118"/>
                    <measurement group_id="O3" value=".019"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.000003</p_value>
            <p_value_desc>Change in BP control were compared by treatment arm using a 1.67% type I error (with Bonferroni adjustment), ie, 1.67% for each assessment of change in proportion with BP under control from baseline to 6 months by SMI, HEI or UC (3 tests).</p_value_desc>
            <method>McNemar</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Change in BP control were compared by treatment arm using a 1.67% type I error (with Bonferroni adjustment), ie, 1.67% for each assessment of change in proportion with BP under control from baseline to 6 months by SMI, HEI or UC (3 tests).</p_value_desc>
            <method>McNemar</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.89</p_value>
            <p_value_desc>Change in BP control were compared by treatment arm using a 1.67% type I error (with Bonferroni adjustment), ie, 1.67% for each assessment of change in proportion with BP under control from baseline to 6 months by SMI, HEI or UC (3 tests).</p_value_desc>
            <method>McNemar</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Systolic Blood Pressure From Baseline to 6 Months</title>
        <time_frame>Baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly calls targeting diet, medication and exercise adherence tailored using the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of non-tailored education about diet, medication and exercise recommendations</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>Treatment as usual for hypertension with no counseling</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Systolic Blood Pressure From Baseline to 6 Months</title>
          <units>mm Hg</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.7" lower_limit="-6.9" upper_limit="-2.5"/>
                    <measurement group_id="O2" value="-5.4" lower_limit="-8.5" upper_limit="-2.3"/>
                    <measurement group_id="O3" value="-2.7" lower_limit="-5" upper_limit="-0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.009</p_value>
            <p_value_desc>Change in SBP were compared by treatment arm using a 1.67% type I error (Bonferroni adjustment), ie, 1.67% for each of the 3 comparisons by arm (6-month-baseline for SMI, HEI and UC separately).</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.008</p_value>
            <p_value_desc>Change in SBP were compared by treatment arm using a 1.67% type I error (Bonferroni adjustment), ie, 1.67% for each of the 3 comparisons by arm (6-month-baseline for SMI, HEI and UC separately).</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.9</p_value>
            <p_value_desc>Change in SBP were compared by treatment arm using a 1.67% type I error (Bonferroni adjustment), ie, 1.67% for each of the 3 comparisons by arm (6-month-baseline for SMI, HEI and UC separately).</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Number of Cardio Exercise Hours From Baseline to 6 Months</title>
        <time_frame>baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Cardio Exercise Hours From Baseline to 6 Months</title>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.29" lower_limit="-1.7" upper_limit="1.1"/>
                    <measurement group_id="O2" value="0.53" lower_limit="-0.6" upper_limit="1.7"/>
                    <measurement group_id="O3" value="-0.43" lower_limit="-1.4" upper_limit="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.880</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.318</p_value>
            <p_value_desc>Change in SBP were compared by treatment arm using a 1.67% type I error (Bonferroni adjustment), ie, 1.67% for each of the 3 comparisons by arm (6-month-baseline for SMI, HEI and UC separately).</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Morisky Score From Baseline to 6 Months</title>
        <description>Morkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4. A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent</description>
        <time_frame>baseline and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 months of non-tailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Morisky Score From Baseline to 6 Months</title>
          <description>Morkisy medication adherence self-report questionnaire, a 4-item questionnaire scored from 0-4. A score of 4 is considered most adherent, and scores of less than 4 are defined as nonadherent</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.25" lower_limit="0.1" upper_limit="0.4"/>
                    <measurement group_id="O2" value="0.25" lower_limit="0.1" upper_limit="0.4"/>
                    <measurement group_id="O3" value="0.14" lower_limit="0" upper_limit="0.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.306</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.205</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diet Stage of Change</title>
        <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Diet Stage of Change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Patients were considered adherent to diet if they reported eating the appropriate diet for hypertension (low in salt and fat with fruits, vegetables, and low-or non-fat dairy products) at least 6 days per week.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87"/>
                    <measurement group_id="O2" value="73"/>
                    <measurement group_id="O3" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69"/>
                    <measurement group_id="O2" value="86"/>
                    <measurement group_id="O3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.011</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.638</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Exercise Stage of Change</title>
        <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise Stage of Change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Exercise adherence was defined as self-reported aerobic exercise for at least 3 days per week for at least 20 minutes each time. We used the lower threshold for exercise adherence due to our patient population with multiple comorbidities, consistent with Federal guidelines for older adults with chronic conditions.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                    <measurement group_id="O2" value="124"/>
                    <measurement group_id="O3" value="126"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.012</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.333</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Stage of Change</title>
        <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Stage-matched Intervention (SMI)</title>
            <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
          </group>
          <group group_id="O2">
            <title>Health Education Intervention (HEI)</title>
            <description>6 monthly calls of nontailored counseling for diet, medication and exercise</description>
          </group>
          <group group_id="O3">
            <title>Usual Care (UC)</title>
            <description>treatment as usual for hypertension</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Stage of Change</title>
          <description>The stages of change were: precontemplation, or no plans to adhere in &lt;6 months; contemplation, or plans to adhere in 1-6 months; preparation, or plans to adhere within 1 month; action, or adherence for &lt;6 months; and maintenance, or adherence for ≥ 6 months. Medication adherence was defined as self-report of taking BP medications as prescribed for at least 6 days per week.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="156"/>
                <count group_id="O2" value="159"/>
                <count group_id="O3" value="170"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Action or Maintenance</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="148"/>
                    <measurement group_id="O2" value="156"/>
                    <measurement group_id="O3" value="163"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Precontemplation, Contemplation or Preparation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.581</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.502</p_value>
            <p_value_desc>Since we are performing 3 tests, we will adjust the type I error to 0.017</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>1 year</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Stage-matched Intervention (SMI)</title>
          <description>6 monthly phone calls of tailored counseling for diet, medication and exercise based on the Transtheoretical Model</description>
        </group>
        <group group_id="E2">
          <title>Health Education Intervention (HEI)</title>
          <description>6 monthly phone calls of nontailored counseling for diet, medication and exercise</description>
        </group>
        <group group_id="E3">
          <title>Usual Care (UC)</title>
          <description>treatment as usual for hypertension</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="176"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="176"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="177"/>
                <counts group_id="E3" subjects_affected="9" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Angina</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="177"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="180"/>
              </event>
              <event>
                <sub_title>hypertensive emergency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="176"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>broken bones</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="176"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="177"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>torn ligament</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="177"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Coronary artery bypass graft</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="176"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="177"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="180"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sundar Natarajan, MD, Staff Physician</name_or_title>
      <organization>Department of Veterans Affairs</organization>
      <phone>212-686-7500 ext 3287</phone>
      <email>Sundar.Natarajan@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

